Living tumour pieces can retain local cells and architecture for a defined experiment outside the body, while losing circulating supply and recruitment.
Fragment and slice preparations retain selected native tissue relationships rather than expanding a selected culture. Composition and function change with sampling, cutting, diffusion, medium and time. A retained vessel does not demonstrate perfusion, and visible immune cells do not establish the required interaction. Ladan's breast-slice assay and Salmon's human lung-slice migration experiments support different questions; neither validates every fragment test or treatment decision.
Maintain viable tissue pieces for a defined comparison while measuring retained populations, quality and an attributed response.
Query for this technology: (TITLE:"Ex vivo tumour fragments and slices" OR ABSTRACT:"Ex vivo tumour fragments and slices") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Ex vivo tumour fragments and slices, not a curated reading list.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/